Successful ex vivo production of RBCs from human umbilical cord blood (hUCB) for transfusion would relieve limitations in the blood donation system, but remains impractical due to the current costly and inefficient suspension culture systems. We previously developed a 3D hollow fibre bioreactor to promote long-term, scalable expansion of red cells using smaller volumes and physiological cytokine concentrations. We extend these studies to further characterise the hematopoietic microenvironment for erythroid expansion and maturation..
We have developed a hematopoietic co-culture system using the hollow fiber bioreactor (HFBR) as a po...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Hematopoietic cell culture, or ex vivo expansion of hematopoietic cells, is an enabling technology w...
Traditional ex vivo hematopoietic culture systems rely on liquid suspension cultures, where differen...
Current in vitro human erythroid culture platforms require abnormally high cytokine supplementation ...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
Blood shortage is one of the biggest concerns of the World Health Organization. The reason: while ar...
Provision of a safe and secure supply of transfusible red blood cells (RBC) is a major global health...
The transplantation of ex vivo expanded mobilized peripheral blood haematopoietic stem cells (PBSC),...
Traditional culture systems for human erythropoiesis lack microenvironmental niches, spatial marrow ...
Transfusion of donor-derived red blood cells (RBC) is the most common form of cellular therapy. Dono...
Umbilical cord blood (UCB) has been shown as a convenient source of hematopoietic stem cells (HSCs) ...
Stem cell-derived erythroid cells hold great potential for the treatment of blood-loss anemia and fo...
Recent work developed a novel, biomimetic, cost effective 3D hollow fibre bioreactor for growing hea...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
We have developed a hematopoietic co-culture system using the hollow fiber bioreactor (HFBR) as a po...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Hematopoietic cell culture, or ex vivo expansion of hematopoietic cells, is an enabling technology w...
Traditional ex vivo hematopoietic culture systems rely on liquid suspension cultures, where differen...
Current in vitro human erythroid culture platforms require abnormally high cytokine supplementation ...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
Blood shortage is one of the biggest concerns of the World Health Organization. The reason: while ar...
Provision of a safe and secure supply of transfusible red blood cells (RBC) is a major global health...
The transplantation of ex vivo expanded mobilized peripheral blood haematopoietic stem cells (PBSC),...
Traditional culture systems for human erythropoiesis lack microenvironmental niches, spatial marrow ...
Transfusion of donor-derived red blood cells (RBC) is the most common form of cellular therapy. Dono...
Umbilical cord blood (UCB) has been shown as a convenient source of hematopoietic stem cells (HSCs) ...
Stem cell-derived erythroid cells hold great potential for the treatment of blood-loss anemia and fo...
Recent work developed a novel, biomimetic, cost effective 3D hollow fibre bioreactor for growing hea...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
We have developed a hematopoietic co-culture system using the hollow fiber bioreactor (HFBR) as a po...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Hematopoietic cell culture, or ex vivo expansion of hematopoietic cells, is an enabling technology w...